{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:52:03Z","timestamp":1787701923548,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T00:00:00Z","timestamp":1458777600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["SpringerPlus"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40064-016-1998-7","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T02:28:18Z","timestamp":1458786498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical significance of serum CA125 in diffuse malignant mesothelioma"],"prefix":"10.1186","volume":"5","author":[{"given":"Xu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-feng","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-yun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,24]]},"reference":[{"issue":"6","key":"1998_CR1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","volume":"153","author":"HR Alexander Jr","year":"2013","unstructured":"Alexander HR Jr, Bartlett DL, Pingpank JF, Libutti SK, Royal R, Hughes MS, Holtzman M, Hanna N, Turner K, Beresneva T, Zhu Y (2013) Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery 153(6):779\u2013786","journal-title":"Surgery"},{"issue":"2","key":"1998_CR2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1245\/s10434-006-9192-8","volume":"14","author":"D Baratti","year":"2007","unstructured":"Baratti D, Kusamura S, Martinetti A, Seregni E, Oliva DG, Laterza B, Deraco M (2007) Circulating CA125 in patients with peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 14(2):500\u2013508","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"1998_CR3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ejso.2009.04.007","volume":"35","author":"D Baratti","year":"2009","unstructured":"Baratti D, Kusamura S, Deraco M (2009) Circulating CA125 and diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 35(11):1198\u20131199","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"1998_CR4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15(2):257\u2013260","journal-title":"Ann Oncol"},{"issue":"5","key":"1998_CR5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/IGC.0b013e31828f7a24","volume":"23","author":"X Chen","year":"2013","unstructured":"Chen X, Zhang J, Cheng W, Chang DY, Huang J, Wang X, Jia L, Rosen DG, Zhang W, Yang D, Gershenson DM, Sood AK, Bast RC Jr, Liu J (2013) CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer. Int J Gynecol Cancer 23(5):815\u2013822","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"1998_CR6","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1378\/chest.07-0013","volume":"132","author":"J Creaney","year":"2007","unstructured":"Creaney J, van Bruggen I, Hof M, Segal A, Musk AW, de Klerk N, Horick N, Skates SJ, Robinson BW (2007) Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma. Chest 132(4):1239\u20131246","journal-title":"Chest"},{"issue":"1","key":"1998_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lungcan.2012.12.008","volume":"80","author":"J Creaney","year":"2013","unstructured":"Creaney J, Dick IM, Dare H, Demelker Y, Nowak AK, Musk AW, Robinson BW (2013) Does CA125 binding to mesothelin impact the detection of malignant mesothelioma? Lung Cancer 80(1):39\u201344","journal-title":"Lung Cancer"},{"issue":"2","key":"1998_CR8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/1097-0142(19930715)72:2<410::AID-CNCR2820720216>3.0.CO;2-G","volume":"72","author":"V Pangher Manzini de","year":"1993","unstructured":"de Pangher Manzini V, Brollo A, Franceschi S, de Matthaeis M, Talamini R, Bianchi C (1993) Prognostic factors of malignant mesothelioma of the pleura. Cancer 72(2):410\u2013417","journal-title":"Cancer"},{"key":"1998_CR9","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual, vol 649. Springer, New York"},{"issue":"10","key":"1998_CR10","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","volume":"13","author":"BD Grigoriu","year":"2007","unstructured":"Grigoriu BD, Scherpereel A, Devos P, Chahine B, Letourneux M, Lebailly P, Gregoire M, Porte H, Copin MC, Lassalle P (2007) Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin Cancer Res 13(10):2928\u20132935","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1998_CR11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-5-50","volume":"5","author":"JA Gubbels","year":"2006","unstructured":"Gubbels JA, Belisle J, Onda M, Rancourt C, Migneault M, Ho M, Bera TK, Connor J, Sathyanarayana BK, Lee B (2006) Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors. Mol Cancer 5(1):50","journal-title":"Mol Cancer"},{"issue":"3","key":"1998_CR12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1445-2197.2006.03579.x","volume":"76","author":"R Hadi","year":"2006","unstructured":"Hadi R, Saunders V, Utkina O, Clingan P, Kam P, Links M, Morris DL (2006) Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy. ANZ J Surg 76(3):156\u2013161","journal-title":"ANZ J Surg"},{"issue":"1B","key":"1998_CR13","first-page":"531","volume":"23","author":"M Hedman","year":"2003","unstructured":"Hedman M, Arnberg H, Wernlund J, Riska H, Brodin O (2003) Tissue polypeptide antigen (TPA), hyaluronan and CA 125 as serum markers in malignant mesothelioma. Anticancer Res 23(1B):531\u2013536","journal-title":"Anticancer Res"},{"issue":"3","key":"1998_CR14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","volume":"113","author":"JE Herndon","year":"1998","unstructured":"Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ (1998) Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113(3):723\u2013731","journal-title":"Chest"},{"issue":"11","key":"1998_CR15","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1097\/JTO.0b013e3182272294","volume":"6","author":"K Hollevoet","year":"2011","unstructured":"Hollevoet K, Nackaerts K, Gosselin R, De Wever W, Bosquee L, De Vuyst P, Germonpre P, Kellen E, Legrand C, Kishi Y, Delanghe JR, van Meerbeeck JP (2011) Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma. J Thorac Oncol 6(11):1930\u20131937","journal-title":"J Thorac Oncol"},{"issue":"6","key":"1998_CR16","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1074\/jbc.M806776200","volume":"284","author":"O Kaneko","year":"2009","unstructured":"Kaneko O, Gong L, Zhang J, Hansen JK, Hassan R, Lee B, Ho M (2009) A binding domain on mesothelin for CA125\/MUC16. J Biol Chem 284(6):3739\u20133749","journal-title":"J Biol Chem"},{"issue":"3","key":"1998_CR17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAT.0b013e3283445e67","volume":"43","author":"SC Kao","year":"2011","unstructured":"Kao SC, Reid G, van Zandwijk N, Henderson DW, Klebe S (2011) Molecular biomarkers in malignant mesothelioma: state of the art. Pathology 43(3):201\u2013212","journal-title":"Pathology"},{"issue":"12","key":"1998_CR18","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1007\/s00330-003-1851-6","volume":"13","author":"M Kebapci","year":"2003","unstructured":"Kebapci M, Vardareli E, Adapinar B, Acikalin M (2003) CT findings and serum ca 125 levels in malignant peritoneal mesothelioma: report of 11 new cases and review of the literature. Eur Radiol 13(12):2620\u20132626","journal-title":"Eur Radiol"},{"key":"1998_CR19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/1471-2407-14-674","volume":"14","author":"M Linch","year":"2014","unstructured":"Linch M, Gennatas S, Kazikin S, Iqbal J, Gunapala R, Priest K, Severn J, Norton A, Ayite B, Bhosle J, O\u2019Brien M, Popat S (2014) A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice. BMC Cancer 14:674","journal-title":"BMC Cancer"},{"issue":"9","key":"1998_CR20","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1054\/bjoc.2000.1174","volume":"82","author":"T Meyer","year":"2000","unstructured":"Meyer T, Rustin GJ (2000) Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer 82(9):1535\u20131538","journal-title":"Br J Cancer"},{"issue":"12","key":"1998_CR21","first-page":"1164","volume":"26","author":"TC Mineo","year":"2012","unstructured":"Mineo TC, Ambrogi V (2012) Malignant pleural mesothelioma: factors influencing the prognosis. Oncology (Williston Park) 26(12):1164\u20131175","journal-title":"Oncology (Williston Park)"},{"issue":"10","key":"1998_CR22","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/cncr.21239","volume":"104","author":"D Nonaka","year":"2005","unstructured":"Nonaka D, Kusamura S, Baratti D, Casali P, Cabras AD, Younan R, Rosai J, Deraco M (2005) Diffuse malignant mesothelioma of the peritoneum. Cancer 104(10):2181\u20132188","journal-title":"Cancer"},{"issue":"15","key":"1998_CR23","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353(15):1591\u20131603","journal-title":"N Engl J Med"},{"issue":"9396","key":"1998_CR24","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","volume":"362","author":"BW Robinson","year":"2003","unstructured":"Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I (2003) Mesothelin-family proteins and diagnosis of mesothelioma. Lancet 362(9396):1612\u20131616","journal-title":"Lancet"},{"issue":"2","key":"1998_CR25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00001622-199104000-00014","volume":"3","author":"PA Ruffie","year":"1991","unstructured":"Ruffie PA (1991) Pleural mesothelioma. Curr Opin Oncol 3(2):328\u2013334","journal-title":"Curr Opin Oncol"},{"issue":"10","key":"1998_CR26","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","volume":"279","author":"A Rump","year":"2004","unstructured":"Rump A, Morikawa Y, Tanaka M, Minami S, Umesaki N, Takeuchi M, Miyajima A (2004) Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion. J Biol Chem 279(10):9190\u20139198","journal-title":"J Biol Chem"},{"issue":"Suppl 4","key":"1998_CR27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/annonc\/mdp134","volume":"20","author":"R Stahel","year":"2009","unstructured":"Stahel R, Weder W, Felip E (2009) Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):73\u201375","journal-title":"Ann Oncol"},{"key":"1998_CR28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1471-2407-13-205","volume":"13","author":"C Tabata","year":"2013","unstructured":"Tabata C, Shibata E, Tabata R, Kanemura S, Mikami K, Nogi Y, Masachika E, Nishizaki T, Nakano T (2013) Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma. BMC Cancer 13:205","journal-title":"BMC Cancer"},{"issue":"11","key":"1998_CR29","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0032-0633(88)90063-3","volume":"36","author":"O Troshichev","year":"1988","unstructured":"Troshichev O, Andrezen V, Vennerstr\u00f8m S, Friis-Christensen E (1988) Magnetic activity in the polar cap\u2014a new index. Planet Space Sci 36(11):1095\u20131102","journal-title":"Planet Space Sci"},{"issue":"1","key":"1998_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/bjc.2012.245","volume":"107","author":"S Bij van der","year":"2012","unstructured":"van der Bij S, Koffijberg H, Burgers JA, Baas P, van de Vijver MJ, de Mol BA, Moons KG (2012) Prognosis and prognostic factors of patients with mesothelioma: a population-based study. Br J Cancer 107(1):161\u2013164","journal-title":"Br J Cancer"},{"issue":"1","key":"1998_CR31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-5002(03)00292-7","volume":"43","author":"RJ Klaveren van","year":"2004","unstructured":"van Klaveren RJ, Aerts JG, de Bruin H, Giaccone G, Manegold C, van Meerbeeck JP (2004) Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma. Lung Cancer 43(1):63\u201369","journal-title":"Lung Cancer"},{"issue":"14","key":"1998_CR32","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21(14):2636\u20132644","journal-title":"J Clin Oncol"},{"issue":"7","key":"1998_CR33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ctrv.2011.01.001","volume":"37","author":"P Zucali","year":"2011","unstructured":"Zucali P, Ceresoli G, De Vincenzo F, Simonelli M, Lorenzi E, Gianoncelli L, Santoro A (2011) Advances in the biology of malignant pleural mesothelioma. Cancer Treat Rev 37(7):543\u2013558","journal-title":"Cancer Treat Rev"}],"container-title":["SpringerPlus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40064-016-1998-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40064-016-1998-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40064-016-1998-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T18:22:51Z","timestamp":1600366971000},"score":1,"resource":{"primary":{"URL":"http:\/\/springerplus.springeropen.com\/articles\/10.1186\/s40064-016-1998-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,24]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1998"],"URL":"https:\/\/doi.org\/10.1186\/s40064-016-1998-7","relation":{},"ISSN":["2193-1801"],"issn-type":[{"value":"2193-1801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,24]]},"article-number":"368"}}